Targeting PLK1 potentiates the antitumor efficacy of EGFR-TKIs through inhibiting the JAK1/STAT3 pathway. [PDF]
Li C +7 more
europepmc +1 more source
<i>GPR176</i> represses mitophagy to promote the progression of osteosarcoma by facilitating mTORC1 activity via PI3K-AKT pathway. [PDF]
Jiang J +6 more
europepmc +1 more source
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer. [PDF]
Siegel F +25 more
europepmc +1 more source
Integrated bioinformatics and network search identify biomarkers and comorbid mechanisms of atrial fibrillation and ischemic stroke. [PDF]
Liu B +9 more
europepmc +1 more source
ERBB2 I655V mutation correlates with efficacy of immunotherapy in gallbladder cancer. [PDF]
Gao Q +5 more
europepmc +1 more source
Corrigendum to Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models. [PDF]
Devarajan R +18 more
europepmc +1 more source
The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study. [PDF]
Yıldız C +10 more
europepmc +1 more source
Lipids regulate epidermal growth factor receptor activation by its ligands. [PDF]
Hutchison JM, Lemmon MA.
europepmc +1 more source
Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System. [PDF]
Moody TW +4 more
europepmc +1 more source
Massive breast fat necrosis with invasive breast cancer: A case report. [PDF]
Zhang A +7 more
europepmc +1 more source

